Team: No. 16 Drive Down A1C Lilly Diabetes Ford Mustang
Crew Chief: Phil Gould
Twitter: @driverRyanReed, @Reed16Team and @RoushFenway
Reed at Richmond
Reed has competed at Richmond Raceway 11 times in the NASCAR Xfinity Series (NXS).
He made his first career NXS start at the track in 2013, earning a 16th-place finish.
Reed has two top-10 finishes at Richmond and an average finish of 13.9.
Last Time at Richmond
Ryan Reed capitalized on consistency at Richmond Raceway and drove his No. 16 Drive Down A1C Lilly Diabetes Ford to a ninth-place finish under the lights. Reed was a top-10 car in practice, qualified 13th and was able to make the right adjustments and maneuvers throughout the race to earn a top-10 finish at the site of his first career NASCAR Xfinity Series (NXS) start.
Reed on Richmond
“Richmond is going to be interesting; we’ve never had a short track kick off our Playoffs. We’ve seen a lot of excitement in the first race of the Playoffs, the drivers are making decisions they normally wouldn’t make because of the Playoffs and I think Richmond is only going to amplify that. With a short track you are obviously able to get to each other a lot easier and try and take advantage of situations that you may not take advantage of in a normal race situation because of the Playoffs. You are going to have to manage your race and be there at the end. It’s going to be a lot of fun and I’m excited to go back. I feel like our short track program has definitely gotten better over the last year or so.”
Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options.
Reed sits 12th going into the first round of the NASCAR Xfinity Series Playoffs this weekend at Richmond Raceway.
Did You Know?
Ryan Reed was diagnosed at the age of 17 with Type 1 Diabetes. Through hard work, perseverance and working with his doctors he’s been able to manage his diabetes and set an example to others.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit http://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.